Maxygen to Present at the 2007 UBS Global Life Sciences Conference

Wednesday, September 19, 2007 General News J E 4
REDWOOD CITY, Calif., Sept. 18 Maxygen, Inc.(Nasdaq: MAXY), a biotechnology company focused on the development of improvedprotein drugs, today announced that it will present at the 2007 UBS GlobalLife Sciences Conference on Tuesday, September 25, 2007 at 12:00 p.m. EasternTime. Russell Howard, Maxygen's chief executive officer, will present.

A live webcast of the presentation can be accessed on Maxygen's website at A replay of the presentation will beavailable starting at approximately 3:00 p.m. Eastern Time on September 25,and will be available until October 27, 2007.

About Maxygen

Maxygen is a biopharmaceutical company focused on developing improvedversions of protein drugs. We look for opportunities where our proprietaryprotein modification technologies can address significant therapeutic needs.Products developed by Maxygen now in clinical trials include a novelinterferon-alpha for the treatment of hepatitis C virus (HCV) infection and anovel G-CSF for the treatment of neutropenia. Maxygen's approach may allow usto leverage the established development and regulatory paths of approveddrugs. We believe this advantage translates to a greater chance ofsuccessfully bringing important new drugs to market.

SOURCE Maxygen, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Visiprise to Present at SAP Adaptive Manufacturing...
Dendreon Announces Webcast Presentation at UBS Lif...